Navigation Links
BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
Date:7/20/2010

Washington, July 20 /PRNewswire-USNewswire/ -- BIO Ventures for Global Health (BVGH) announced today that it is expanding to the West Coast with the opening of a new San Francisco headquarters office. The expansion provides BVGH the opportunity to work even more closely with the world class biotech and investor communities on both coasts.

"We are very excited about our expansion and new location in the Bay area, one of the premier biotech centers," says Don Joseph, JD, Chief Operating Officer of BVGH.  "By establishing a West Coast location in addition to our ongoing presence in Washington, D.C., BVGH will be better able to connect with biotech companies and investors, regardless of their location, as we seek to expand companies' involvement in addressing neglected diseases of the developing world."

BVGH also announced the appointment of two new senior staff.  Jacqueline Papkoff, PhD, was appointed Vice President of Global Health Connect.  Global Health Connect is a new network created to link biopharmaceutical companies with product development partnerships, academics, NGOs, developing country researchers, and other experts involved in product research and development for neglected diseases. Papkoff has worked for more than 20 years in the biotech and pharmaceutical industry and has extensive scientific leadership, management, and business experience, including senior positions at diaDexus, Megabios, SUGEN, and Hoechst. Before joining BVGH, she served as a biotherapeutics R&D consultant as well as Chief Scientific Officer of CFD Therapeutics, a preclinical cancer therapeutic antibody company.

Nadine Weich, PhD, was appointed Senior Director of Scientific Affairs.  Weich most recently served as Project Team Leader for Immunology at Genentech. Before joining Genentech, she was the Director of the Department of Inflammation at Millennium Pharmaceuticals. She has more than 17 years of experience in the biopharmaceutical industry, where she focused on the research and development of antibody/protein and small molecule therapeutics for tissue growth and repair, cardiovascular, inflammation (infectious and autoimmune diseases), and oncology indications. Weich heads a Scientific Affairs department that includes Elizabeth Ponder, PhD, who brings training and experience in infectious diseases and parasitology.

"It is exciting to fill out our team with highly capable individuals who have the skills and experiences to significantly advance our programs," says Melinda Moree, BVGH Chief Executive Officer. "BVGH has doubled in size over the past year and is now staffed up to a critical mass, filled with complementary experience from the biotech, pharma, and global health sectors. This powerful combination will allow BVGH to increase the depth of its work and the creativity of its proposed solutions as we continue to create incentives and solutions to engage the innovation of the biopharmaceutical industry in addressing the crucial work of global health."

About BIO Ventures for Global Health

BIO Ventures for Global Health is a non-profit organization whose mission is to save lives by accelerating the development of novel biotechnology-based drugs, vaccines, and diagnostics to address the unmet medical needs of the developing world. The organization spurs biotech industry involvement in global health product development by increasing biotech and global health partnerships, designing and advocating for compelling market-based incentives, and synthesizing and disseminating critical information and quantitative analysis. For more information, please visit www.bvgh.org.


'/>"/>
SOURCE BIO Ventures for Global Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 7 Health Ventures Invests in Tulip Medical
2. Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures
3. ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures
4. Fulcrum Ventures Leads $1.25 Million Investment in Path-Tec, LLC
5. Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
6. iPierian Closes $22 Million Series B Financing Led By Google Ventures
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Directors Forum: PEPFAR and the Global AIDS Response
10. Alfacell Corporation to Present at UBS Global Life Sciences Conference
11. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... -- ResMed (NYSE: RMD ), BMC (Peking, ... Winter Haven, Florida ) gaben heute bekannt, dass ... globalen Rechtsstreitigkeiten zwischen den Parteien geeinigt haben. BMC und ... im Tausch gegen Lizenzgebühren an ResMed gestattet, und ResMed ... in Florida anhängige Rechtsverfahren zwischen ...
(Date:1/23/2017)... 2017 InDex Pharmaceuticals Holding AB (publ) today ... congress of the European Crohn,s and Colitis Organisation (ECCO). The ECCO ... focus on inflammatory bowel disease (IBD). The congress is held in ... ... to again having been selected to present data at the largest ...
(Date:1/21/2017)... DUBLIN , Jan 20, 2017 ... "US Clinical Laboratory Testing Market By Type of Test (Tumor, ... Independent), & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS ... ... an attractive destination for healthcare services, market segments, especially clinical ...
Breaking Medicine Technology:
(Date:1/22/2017)... , ... January 22, 2017 , ... Zifam Pinnacle, an ... the world, recently met with big-name retail buyers at the January ECRM Trade Show ... efficacy and uses the utmost safety standards in all of its creations to help ...
(Date:1/21/2017)... FL (PRWEB) , ... January 21, 2017 , ... Caronlab ... recently attended the January ECRM Trade Show in Hilton Head, SC, where it benefited ... reputation for the quality of its beauty and wellness products. At this trade show, ...
(Date:1/21/2017)... ... 21, 2017 , ... Seamild, the largest manufacturer of oats in China, is ... and founder. As Oat is recognized globally as one of the healthiest cereals, XieQingkui, ... believes it is a move to sow the seed of good karma. Buddhism spirit ...
(Date:1/21/2017)... ... January 21, 2017 , ... Northern California Medical Associates (NCMA) ... their multi-specialty medical group. The dermatology practice provides general dermatologic treatment, outpatient surgery, ... add this excellent dermatology practice to our group’s medical services,” explains NCMA CEO, ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
Breaking Medicine News(10 mins):